OpenSecrets.org @OpenSecretsDC
As expensive gene therapies emerge to treat rare diseases, representatives of #BigPharma lobby for new pricing mechanisms to accommodate them. Drug manufacturers are focused on ensuring that someone will pay for the prescription — no matter the cost. https://t.co/yUZNxec1Ud — PolitiTweet.org